Cited 0 times in Scipus Cited Count

Effects of influenza immunization on pneumonia in the elderly

DC Field Value Language
dc.contributor.authorHeo, JY-
dc.contributor.authorSong, JY-
dc.contributor.authorNoh, JY-
dc.contributor.authorChoi, MJ-
dc.contributor.authorYoon, JG-
dc.contributor.authorLee, SN-
dc.contributor.authorCheong, HJ-
dc.contributor.authorKim, WJ-
dc.date.accessioned2020-01-09T06:41:19Z-
dc.date.available2020-01-09T06:41:19Z-
dc.date.issued2018-
dc.identifier.issn2164-5515-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/17961-
dc.description.abstractInfluenza virus is a common pathogen implicated in respiratory tract infections, annually affecting up to 20% of the general population, and pneumonia is a leading cause of death after influenza infection. Post-influenza pneumonia is especially common in the elderly and chronically ill patients. The risk of post-influenza pneumonia is significantly increased according to the number of concurrent comorbidities. Vaccination is the primary measure used to abate influenza epidemics and associated complications. In meta-analyses, influenza vaccine significantly reduces pneumonia- and influenza-related hospitalizations, with a vaccine effectiveness of 25-53%. However, considering the poor effectiveness of conventional influenza vaccines in the elderly, several highly immunogenic influenza vaccines have been developed. Further evaluations of the comparative effectiveness of diverse vaccine formulations are warranted to assess their utility for preventing influenza infection, post-influenza pneumonia, and related hospitalization/mortality. Based on cost-effectiveness and budget impact analysis, influenza vaccination strategies should be tailored in the elderly.-
dc.language.isoen-
dc.subject.MESHAged-
dc.subject.MESHChronic Disease-
dc.subject.MESHCost-Benefit Analysis-
dc.subject.MESHHospital Mortality-
dc.subject.MESHHospitalization-
dc.subject.MESHHumans-
dc.subject.MESHInfluenza Vaccines-
dc.subject.MESHInfluenza, Human-
dc.subject.MESHMeta-Analysis as Topic-
dc.subject.MESHPneumonia-
dc.subject.MESHRisk-
dc.subject.MESHVaccination-
dc.subject.MESHVaccines, Inactivated-
dc.titleEffects of influenza immunization on pneumonia in the elderly-
dc.typeArticle-
dc.identifier.pmid29135343-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861791/-
dc.subject.keywordAged-
dc.subject.keywordImmunization-
dc.subject.keywordInfluenza-
dc.subject.keywordPneumonia-
dc.subject.keywordVaccine effectiveness-
dc.contributor.affiliatedAuthor허, 중연-
dc.type.localJournal Papers-
dc.identifier.doi10.1080/21645515.2017.1405200-
dc.citation.titleHuman vaccines & immunotherapeutics-
dc.citation.volume14-
dc.citation.number3-
dc.citation.date2018-
dc.citation.startPage744-
dc.citation.endPage749-
dc.identifier.bibliographicCitationHuman vaccines & immunotherapeutics, 14(3). : 744-749, 2018-
dc.identifier.eissn2164-554X-
dc.relation.journalidJ021645515-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Infectious Diseases
Files in This Item:
29135343.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse